Tag

Pcos

All articles tagged with #pcos

health8 days ago•3 min saved

PMOS: A new name for PCOS aims to improve diagnosis and care

Experts rename polycystic ovary syndrome to polyendocrine metabolic ovarian syndrome (PMOS) to reflect its broader hormonal and metabolic features, not just ovarian cysts; diagnosis centers on irregular periods and signs of high androgens, with infertility and pregnancy risks acknowledged. Treatment emphasizes lifestyle changes and individualized options such as metformin, anti-androgens, and hormonal birth control based on fertility goals.

via PBS|

#endocrinology #health #infertility

health9 days ago•4 min saved

PMOS: A Fresh Name for PCOS Emphasizing Multisystem Metabolic Roots

PMOS, the official rename of PCOS (polycystic ovarian syndrome), reframes the condition as a multisystem endocrine and metabolic disorder driven largely by insulin resistance, not just ovarian cysts. The Lancet consensus (May 12, 2026) involved about 22,000 experts and 56 organizations to improve diagnosis, reduce stigma, and guide treatment toward metabolic health and personalized care. Diagnosis now emphasizes signs of androgen excess, menstrual history, and metabolic testing, with management focusing on lifestyle changes, glucose control, and targeted therapies, while fertility considerations are addressed when relevant. It is lifelong but manageable with proper care and advocacy.

via NewYork-Presbyterian|

#endocrine-metabolic-disorder #health #insulin-resistance

column11 days ago•60 min saved

PMOS reveals the long road to truly personalized health

Victoria Song argues that renaming PCOS to PMOS reflects a broader hormonal and metabolic condition, and that personalized health tech is not yet capable of reliably addressing chronic illnesses. While wearables and AI promise tailored guidance, PMOS manifests differently across individuals, interacts with insulin resistance and medications, and is influenced by factors like hormonal contraception, making universal personalization elusive. Despite industry optimism, real-world personalization still requires significant self-tracking, medical input, and trial-and-error, highlighting a gap between hype and what current science and healthcare systems can safely deliver.

via The Verge|

#column #health-tech #pcos

health-and-medicine12 days ago•156 min saved

PMOS: New global name for PCOS to spotlight systemic health

After a 14-year global consensus involving 56 organizations and about 22,000 participants, Polycystic Ovary Syndrome is officially renamed Polyendocrine Metabolic Ovarian Syndrome (PMOS) to reflect its systemic hormonal and metabolic nature. The rename aims to reduce stigma, improve diagnosis, and align clinical practice over the next three years, with around 1 in 8 women affected by PMOS. The effort was led by researchers including Prof. Helena Teede and advocacy by Lorna Berry, highlighting the shift away from a cyst-centric view to a broader endocrine health perspective.

via Ground News|

#endocrinology #health-and-medicine #pcos

health13 days ago•37 min saved

PCOS Gets a Fresh Name: PMOS Aims to Improve Diagnosis and Care

Global experts have renamed polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its multisystem effects. The change, backed by 56 organizations after more than a decade of consultation and published in The Lancet, aims to reduce diagnostic delays and misperceptions by emphasizing endocrine and metabolic factors over ovarian cysts, potentially guiding future research toward metabolic roots like insulin resistance and chronic inflammation and reshaping how the condition is diagnosed and treated.

via Healthline|

#diagnosis-treatment #health #multisystem-disease

health13 days ago•6 min saved

PMOS: A new name for PCOS to improve diagnosis and care

PMOS—polyendocrine metabolic ovarian syndrome—replaces PCOS to better reflect its metabolic and endocrine nature and reduce misdiagnosis; the rename, published in The Lancet after 14 years of work, aims to improve care. PMOS features irregular periods and excess androgens, can cause acne or hair changes, and is linked to infertility and metabolic risks; treatment focuses on lifestyle changes (diet, exercise, sleep) and personalized options like Metformin, anti-androgens, or hormonal birth control. The change seeks to raise awareness and better tailor care for patients.

via Click2Houston|

#endocrine-society #health #infertility

health14 days ago•8 min saved

PCOS Gets a Fresh Identity: PMOS Aims to Reflect Multisystem Roots

A global health consortium renames polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to better capture its multisystem nature, remove the misleading focus on ovaries, and reduce stigma. After 14 years of collaboration, the group plans to push PMOS into ICD classifications within three years and raise public and professional awareness. The condition affects about 170 million people worldwide, with up to 70% undiagnosed, and often involves metabolic, endocrine, psychological, and dermatological symptoms beyond reproduction. The renaming emphasizes insulin resistance and diabetes risk, potentially guiding research, screening, and treatment, including the continued, and sometimes off-label, use of drugs like metformin. The Lancet policy paper outlines the strategy to educate globally and secure official ICD updates.

via ScienceAlert|

#endocrinology #health #insulin-resistance

health14 days ago•5 min saved

PCOS Rebrands as PMOS to spotlight endocrine-metabolic ovarian syndrome

Global experts publish in The Lancet a multiyear, multistakeholder process renaming polycystic ovary syndrome (PCOS) to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to avoid the cyst misnomer and better reflect its hormonal and metabolic features, with an eight‑stage plan—from dissemination and resource development to health‑system integration, policy alignment, and international guideline updates—aimed at clearer diagnosis and improved care.

via Contemporary OB/GYN|

#endocrinology #health #health-policy

health14 days ago•6 min saved

PCOS renamed PMOS to better reflect broad metabolic and endocrine health risks

Health researchers have renamed PCOS to PMOS (polyendocrine metabolic ovarian syndrome) to better reflect its wide hormonal and metabolic effects; a global consortium says the old name contributed to delayed diagnosis, stigma, and siloed research. The change could alter clinical care by prompting broader metabolic and cardiovascular screening, expand funding beyond reproductive health, and spur new treatments for the roughly 10–13% of reproductive-age women affected.

via The New York Times|

#endocrinology #health #metabolic-syndrome

health14 days ago•30 min saved

PCOS Gets a New Name: PMOS Signals a Broader Endocrine Disorder

A Lancet-published renaming led by endocrinologist Helena Teede changes polycystic ovary syndrome (PCOS) to polyendocrine metabolic ovarian syndrome (PMOS) to reflect the disorder’s wide metabolic and cardiovascular effects. Diagnosis shifts away from ovarian cysts, using 2 of 3 criteria (androgens, irregular menses, or high AMH/ovarian follicles), with ultrasound needing less emphasis. The rename is intended to broaden research funding and change treatment approaches beyond fertility, with PMOS slated to replace PCOS in ICD classification by 2028, though some opposition from those tied to the PCOS branding is expected.

via Time Magazine|

#diagnosis #endocrinology #health

health14 days ago•3 min saved

Polycystic Ovarian Syndrome Rebranded as PMOS to Reflect Full Health Impact

Medical experts say PCOS should be renamed polyendocrine metabolic ovarian syndrome (PMOS) to capture its wide-ranging effects on metabolic, endocrine, cardiovascular, reproductive, and mental health, with the aim of improving diagnosis, treatment, and research.

via PhillyVoice|

#health #medical-terminology #metabolic-syndrome

health15 days ago•6 min saved

PMOS Renames PCOS to Reflect Metabolic-Endocrine Reality for 170 Million Women

Global experts and patient groups have renamed Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome (PMOS) to better reflect its hormonal and metabolic features and reduce stigma; the shift, supported by more than 50 organizations and published in The Lancet after 14 years of work, aims to improve diagnosis and care for about 170 million women worldwide, with full implementation in the 2028 international guideline update and new evidence showing no increase in abnormal ovarian cysts.

via Endocrine Society|

#diagnosis #endocrine #health

health15 days ago•18 min saved

PMOS rename reframes PCOS as a broader endocrine-metabolic condition

After more than a decade of global consultation, polycystic ovary syndrome (PCOS) has been renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its hormonal and metabolic impacts. Led by Prof. Helena Teede and backed by 56 medical and patient groups across six continents, the change aims to reduce misunderstanding and improve diagnosis and care, with the new name to be incorporated into international guidelines by 2028.

via The Guardian|

#endocrinology #health #pcos

health15 days ago•61 min saved

PCOS is renamed PMOS to reflect endocrine-metabolic roots

Live Science reports that polycystic ovary syndrome (PCOS) will be renamed polyendocrine metabolic ovarian syndrome (PMOS) to better reflect its hormonal and metabolic nature. The term “polycystic” is considered inaccurate since arrested follicles, not cysts, drive many features, and the name has contributed to confusion and stigma. The change was led by an international coalition of 56 organizations, with input from thousands of patients and clinicians, and is set to roll out over about three years. The acronym may continue as PMOS, and there are plans to update diagnostic language beyond ovaries to mirror the systemic endocrine-metabolic effects; this may also stimulate broader research and awareness beyond gynecology.

via Live Science|

#endocrinology #health #pcos

health1 month ago•8 min saved

Metformin Reimagined: A 100-Year-Old Drug Tackles Hyperemesis Gravidarum

A health feature follows researchers and patients exploring metformin, a diabetes drug, as a potential preventive treatment for hyperemesis gravidarum (HG) by modulating the nausea-related hormone GDF15. Early observational data suggest taking metformin before conception may significantly reduce HG risk, with clinical trials in the works. The drug’s affordability, safety history, and broad off-label use—ranging from fertility in PCOS to obesity and potential antiaging effects—have spurred widespread interest, though more rigorous research is needed. The piece also shares the lived experience of HG and a patient hopeful that metformin could improve future pregnancies.

via Women's Health|

#gdf15 #health #hyperemesis-gravidarum